Ocean Biomedical, Inc. (NASDAQ:OCEAW) Sees Significant Drop in Short Interest

Ocean Biomedical, Inc. (NASDAQ:OCEAW) was the recipient of a large drop in short interest in March. As of March 15th, there was short interest totalling 4,000 shares, a drop of 42.0% from the February 28th total of 6,900 shares. Based on an average daily volume of 58,100 shares, the short-interest ratio is currently 0.1 days.

Ocean Biomedical Stock Down 8.7 %

Ocean Biomedical stock opened at $0.02 on Friday. The stock has a 50-day simple moving average of $0.03 and a 200 day simple moving average of $0.03. Ocean Biomedical has a 12-month low of $0.02 and a 12-month high of $0.36.

About Ocean Biomedical

Ocean Biomedical, Inc, a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, infectious diseases, and inflammation. The company is developing mono-specific and bi-specific humanized monoclonal antibodies (mAb) product candidates targeting Chi3l1 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.